TrianglePUBLICATIONS · 22450929
Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Jpn J Clin Oncol
- Publication date
- 2012 May
- First author
- Qi WX
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Qi WX
- type
- Author
- name
- He AN
- type
- Author
- name
- Tang LN
- type
- Author
- name
- Shen Z
- type
- Author
- name
- Lin F
- type
- Author
- name
- Yao Y
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Qi WX
- type
- Author
- name
- He AN
- type
- Author
- name
- Tang LN
- type
- Author
- name
- Shen Z
- type
- Author
- name
- Lin F
- type
- Author
- name
- Yao Y
- type
- Author
- bibliography ids
- nci-bib-11fa34837e810d37e8a14a5f
- book metadata
- content sha256
- fc61feef68e4e994d30cd8070cb0b414f129fc575538651341d51f2566f6b02b
- document type
- citation
- dois
- 10.1093/jjco/hys030
- electronic publication date
- display
- 2012 Mar 26
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22450929
- immutable id
- pubmed:22450929@fc61feef68e4e994d30cd8070cb0b414f129fc575538651341d51f2566f6b02b
- journal
- abbreviation
- Jpn J Clin Oncol
- issn electronic
- 1465-3621
- issn print
- 0368-2811
- issue
- 5
- name
- Japanese journal of clinical oncology
- nlm unique id
- 0313225
- pages
- 427-31
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22450929
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- 99c84b61c7f3f8ae36a8f68ffc707fd0e4a95dc4c9c8b5a306add4acf9fcbc82
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 May
- precision
- month
- year
- 2012
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.
Preserved source evidence · Not medical advice